Renaissance Technologies
ICVX

Renaissance Technologies’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Renaissance Technologies’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-151,200
Closed -$2.38M – 4213
2023
Q4 		$2.38M Buy
+151,200
New +$1.46M ﹤0.01% 1846
2023
Q3 		– Sell
-15,400
Closed -$153K – 4242
2023
Q2 		$153K Sell
15,400
-22,100
-59% -$177K ﹤0.01% 3354
2023
Q1 		$218K Buy
37,500
+16,500
+79% +$143K ﹤0.01% 3242
2022
Q4 		$167K Buy
21,000
+5,900
+39% +$25.3K ﹤0.01% 3483
2022
Q3 		$48K Buy
+15,100
New +$94.5K ﹤0.01% 3770

Renaissance Technologies's ICVX Position: Q1 2024 in Review

Renaissance Technologies sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 151,200 shares — an estimated $2.38M sold.

Renaissance Technologies first reported a position in ICVX in Q3 2022 and held it in 5 quarters. The position peaked at $2.38M in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Renaissance Technologies reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Renaissance Technologies sold 151,200 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $2.38M.
  • Renaissance Technologies first reported a position in Icosavax, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • Renaissance Technologies's Icosavax, Inc. Common Stock position peaked at $2.38M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.